Dr Nimesh Navin Shah, MD | |
2675 N Decatur Rd, Suite 609, Decatur, GA 30033-6131 | |
(404) 501-9170 | |
(404) 974-2699 |
Full Name | Dr Nimesh Navin Shah |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 14 Years |
Location | 2675 N Decatur Rd, Decatur, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245551563 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 074098 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Emory Decatur Hospital | Decatur, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Emory Specialty Associates, Llc | 3476559782 | 430 |
News Archive
Now, in a study that appears in the May 10, 2012 issue of the journal Neuron, scientists from the Florida campus of The Scripps Research Institute have pinpointed a mechanism that is essential for forming memories in the first place and, as it turns out, is equally essential for eliminating them after memories have formed.
Bayer HealthCare and Onyx Pharmaceuticals today announced that Bayer HealthCare has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the oral multi-kinase inhibitor regorafenib for the treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) in patients whose disease has progressed despite prior treatment.
Johns Hopkins scientists, reporting in the journal Molecular Psychiatry, have identified a small region on chromosome 2 that is associated with increased risk for attempted suicide. This small region contains four genes, including the ACP1 gene, and the researchers found more than normal levels of the ACP1 protein in the brains of people who had committed suicide. This protein is thought to influence the same biological pathway as lithium, a medication known to reduce the rate of suicidal behavior.
Menarini Silicon Biosystems, the pioneer of liquid biopsy and single cell technologies, announced today that results from a new study presented at the virtual 2020 meeting of the American Society of Clinical Oncology suggest that circulating tumor cell counts may be useful in determining long-term prognosis and guiding treatment selection in patients with metastatic castrate sensitive prostate cancer.
› Verified 6 days ago
Entity Name | Emory Specialty Associates, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407864168 PECOS PAC ID: 3476559782 Enrollment ID: O20061010000447 |
News Archive
Now, in a study that appears in the May 10, 2012 issue of the journal Neuron, scientists from the Florida campus of The Scripps Research Institute have pinpointed a mechanism that is essential for forming memories in the first place and, as it turns out, is equally essential for eliminating them after memories have formed.
Bayer HealthCare and Onyx Pharmaceuticals today announced that Bayer HealthCare has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the oral multi-kinase inhibitor regorafenib for the treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) in patients whose disease has progressed despite prior treatment.
Johns Hopkins scientists, reporting in the journal Molecular Psychiatry, have identified a small region on chromosome 2 that is associated with increased risk for attempted suicide. This small region contains four genes, including the ACP1 gene, and the researchers found more than normal levels of the ACP1 protein in the brains of people who had committed suicide. This protein is thought to influence the same biological pathway as lithium, a medication known to reduce the rate of suicidal behavior.
Menarini Silicon Biosystems, the pioneer of liquid biopsy and single cell technologies, announced today that results from a new study presented at the virtual 2020 meeting of the American Society of Clinical Oncology suggest that circulating tumor cell counts may be useful in determining long-term prognosis and guiding treatment selection in patients with metastatic castrate sensitive prostate cancer.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Nimesh Navin Shah, MD 2675 N Decatur Rd, Suite 609, Decatur, GA 30033-6131 Ph: (404) 501-9170 | Dr Nimesh Navin Shah, MD 2675 N Decatur Rd, Suite 609, Decatur, GA 30033-6131 Ph: (404) 501-9170 |
News Archive
Now, in a study that appears in the May 10, 2012 issue of the journal Neuron, scientists from the Florida campus of The Scripps Research Institute have pinpointed a mechanism that is essential for forming memories in the first place and, as it turns out, is equally essential for eliminating them after memories have formed.
Bayer HealthCare and Onyx Pharmaceuticals today announced that Bayer HealthCare has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the oral multi-kinase inhibitor regorafenib for the treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) in patients whose disease has progressed despite prior treatment.
Johns Hopkins scientists, reporting in the journal Molecular Psychiatry, have identified a small region on chromosome 2 that is associated with increased risk for attempted suicide. This small region contains four genes, including the ACP1 gene, and the researchers found more than normal levels of the ACP1 protein in the brains of people who had committed suicide. This protein is thought to influence the same biological pathway as lithium, a medication known to reduce the rate of suicidal behavior.
Menarini Silicon Biosystems, the pioneer of liquid biopsy and single cell technologies, announced today that results from a new study presented at the virtual 2020 meeting of the American Society of Clinical Oncology suggest that circulating tumor cell counts may be useful in determining long-term prognosis and guiding treatment selection in patients with metastatic castrate sensitive prostate cancer.
› Verified 6 days ago
Barath Ram Badrinathan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2701 N Decatur Rd, Decatur, GA 30033 Phone: 404-501-2930 | |
Kevin Gary Mccowan, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2675 N Decatur Rd, Suite 609, Decatur, GA 30033 Phone: 404-501-9170 Fax: 404-974-2699 | |
Dr. Eugene Orville Harrison, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2665 N Decatur Rd, Ste 350, Decatur, GA 30033 Phone: 404-501-7081 Fax: 404-419-1680 | |
Sindhu Srinivas, Surgery Medicare: Not Enrolled in Medicare Practice Location: 1670 Clairmont Rd, Decatur, GA 30033 Phone: 570-271-6211 | |
Andrei Carol Stieber, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2665 N Decatur Rd, Suite 730, Decatur, GA 30033 Phone: 404-508-4320 | |
Julie F Mcgill, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1045 Sycamore Dr, Decatur, GA 30030 Phone: 404-501-7081 Fax: 404-419-1680 |